Skip to main content
. Author manuscript; available in PMC: 2010 Oct 17.
Published in final edited form as: J Immunol. 2010 Sep 3;185(7):4148–4153. doi: 10.4049/jimmunol.1001536

FIGURE 3.

FIGURE 3

Conversion of Tregs into IL-17–producing cells requires TGF-β and IL-1β. A, Tconvs and Tregs were cultured with anti-CD3 mAb and APCs. TGF-β neutralizing Ab or isotype control was added, and production of IL-17A was measured on day 3. *p = 0.003. Representative results of four experiments are shown. B, Tconvs and Tregs were cultured with anti-CD3 mAb and APCs, either individually or mixed at a 1:1 ratio, and IL-6 was measured. C, Tconvs and Tregs were mixed at a 1:1 ratio, cultured with anti-CD3 mAb and APCs in the presence of media, anti-IL-6 neutralizing Ab, anti-IL-6 receptor blocking Ab, or their combination, and IL-17A was assessed. Representative results of three experiments are shown. D, Tconvs and Tregs were cultured with anti-CD3 mAb and APCs in the absence or presence of IL-1β neutralizing Ab. Results are representative of four experiments. E, TcWT or TcKO were cultured with Tregs from TrWT or from TrKO with anti-CD3 mAb and APCs, and production of IL-17A was assessed on day 3. Representative results of two experiments are shown. TcKO, Tconvs from IL-1R1−/− mice; TcWT, Tconvs from wild type mice; TrWT, Tregs from wild type mice; TrKO, Tregs from IL-1R1−/− mice.